The Role of Radiotherapy in the Management of Non-Malignant Diseases of the Head and Neck

The role of radiotherapy in the management of benign diseases is ever expanding. Non-malignant entities of the head and neck are particularly complex and represent therapeutic challenges given the potential for treatment-associated morbidities.

Nasal Cavity and Paranasal Sinus Tumors: A Multi-Disciplinary Discussion

The management of patients with nasal cavity and paranasal sinus tumors is challenging and constantly evolving. It often requires true trimodality care involving radiation oncology, otolaryngology and medical oncology, along with a variety of different supportive services.

Practical Radiation Oncology Program 2026

This program is designed to address the needs of a community practice physician and includes disease site reviews, interactive case-based discussions, a strategic dialogue with the ASTRO CEO and a radiation oncology practice overview.

Palliative Care Essentials

This multi-session course provides a practical, evidence-based overview of contemporary palliative radiation oncology, with a focus on optimizing symptom relief, treatment selection, and supportive care for patients with advanced malignancies.

Gray Zone - Not Quite Metastatic, Not Quite Local: Nasopharyngeal Carcinoma with Solitary Vertebral Metastases

The ultimate goal of radiation oncology research is to improve clinical care. As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.

The Journey of the Unknown Primary in the HPV Era: Evaluation, Treatment, Surveillance and Management of Oligometastatic Disease

Management of unknown primary head and neck squamous cell carcinomas has evolved as the incidence of p16 positive disease among head and neck cancer patients has increased.

Definitive Treatment in Transition: De-Escalation, Biomarkers and Immunotherapy in Head and Neck Radiation Oncology

Immunotherapy has transformed the care of patients with recurrent/metastatic head and neck cancer but integration into definitive management has been more challenging.

Gray Zone - Reirradiation After Incomplete Salvage in p16-Positive Oropharyngeal Carcinoma: How Far Should We Go?

The ultimate goal of radiation oncology research is to improve clinical care. As a specialty, we tackle diverse research questions, addressing every type of cancer and encompassing cancer biology and radiation physics.

2026 Multidisciplinary Head and Neck Cancers Symposium onDemand

The 2026 Multidisciplinary Head and Neck Cancers Symposium is a two-and-a-half-day meeting featuring interactive and case-based educational sessions that cover new multidisciplinary therapies, imaging, immunotherapy, treatment guidelines, supportive care and understanding disparities in head and

Definitive Treatment in Transition: De-Escalation, Biomarkers and Immunotherapy in Head and Neck Radiation Oncology Webinar

Immunotherapy has transformed the care of patients with recurrent/metastatic head and neck cancer but integration into definitive management has been more challenging.

Pages

Subscribe to RSS - Head and Neck